Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer

Kgatle, M. M., Kalla, A. A., Islam, M. M., Sathekge, M., & Moorad, R. (2016). Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy. Prostate Cancer, 2016(), 77-87. https://doi.org/10.1155/2016/5653862
平思遠（2003）。Therapeutic Roles and Molecular Mechanisms of Antioxidants in Prostate Cancer〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-0707200816034269
Bonkhoff, H. (2012). Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer. Prostate Cancer, 2012(), 152-163. https://doi.org/10.1155/2012/593241
Yun, E. J., & Hsieh, J. T. (2014). Cancer Stem Cell in Castration-Resistant Prostate: Altering the Adaptation Landscape with New Therapeutic Implication. Adaptive Medicine, 6(3), 89-94. https://doi.org/10.4247/AM.2014.ABE093
Leeuwen, P. J. V., Siriwardana, A., Roobol, M., Ting, F., Nieboer, D., Thompson, J., Delprado, W., Haynes, A. M., Brenner, P., & Stricker, P. (2016). Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies. Prostate Cancer, 2016(), 89-95. https://doi.org/10.1155/2016/7105678